Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis

Katrina L Ellis1,2, Jing Pang1, David Chieng3

  • 1School of Medicine, University of Western Australia, Perth, Australia.

Clinical Cardiology
|February 27, 2018
PubMed

Insights

Elevated lipoprotein(a) (Lp[a]) and familial hypercholesterolemia (FH) are common in coronary care unit patients and increase premature coronary artery disease (CAD) risk, especially when combined.

Area of Science:

  • Cardiology
  • Genetics
  • Lipidology

Background:

  • Familial hypercholesterolemia (FH) and elevated lipoprotein(a) (Lp[a]) are inherited lipid disorders.
  • Their prevalence, co-occurrence, and association with premature coronary artery disease (CAD) in coronary care unit (CCU) patients require definition.

Purpose of the Study:

  • To determine the frequencies of elevated Lp(a) and FH in CCU patients.
  • To investigate their independent and combined associations with premature CAD.

Main Methods:

  • Measured plasma Lp(a) and LDL-C in consecutive CCU patients with acute coronary syndrome or prior CAD.
  • Defined elevated Lp(a) as ≥0.5 g/L and FH phenotype as LDL-C ≥5 mmol/L.
  • Used logistic regression to assess the relationship with premature CAD (age <60 years).

Main Results:

  • Elevated Lp(a) and FH were found in 27.0% and 11.6% of 316 patients, respectively.
  • Both conditions were more frequent in patients with premature CAD (32.0% and 15.5%) compared to others.
  • Elevated Lp(a) alone, FH alone, and their combination increased premature CAD risk by 1.9, 3.2, and 5.3-fold, respectively.

Conclusions:

  • Elevated Lp(a) and FH are common in CCU patients and associated with premature CAD.
  • The combination of elevated Lp(a) and FH significantly elevates CAD risk.
  • Routine screening for elevated Lp(a) and FH is recommended for CCU patients.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
303
Protein Families02:47

Protein Families

Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
17.2K
Protein Families02:47

Protein Families

4.5K
Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
10.0K
Gene Families01:57

Gene Families

3.9K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
305